Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene

Q. M. Ralph, M. J. Brisco, D. E. Joshua, R. Brown, J. Gibson, A. A. Morley

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

The Ig heavy chain (IgH) gene was used as a marker to investigate clonal succession and the origin of the neoplastic cell in multiple myeloma. The polymerase chain reaction (PCR) was used to amplify a section of the rearranged IgH gene at diagnosis and at progression in 21 patients who had exhibited a plateau phase. A monoclonal PCR product was seen for 16 of the patients and the product present at progression was of the same molecular weight as that at diagnosis. This finding suggests that the IgH rearrangement present at diagnosis and progression was the same. This was confirmed by sequencing the IgH gene in 10 patients. The IgH genes were found to be hypermutated at diagnosis, but no further hypermutation occurred during the course of the disease. The results provide evidence that the neoplastic cell in myeloma may originate as a memory B cell, plasmablast, or plasma cell, and suggest that progression beyond the plateau phase is not caused by clonal succession.

Original languageEnglish
Pages (from-to)202-206
Number of pages5
JournalBlood
Volume82
Issue number1
DOIs
Publication statusPublished - 1 Jul 1993
Externally publishedYes

Fingerprint Dive into the research topics of 'Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene'. Together they form a unique fingerprint.

  • Cite this